Eltanexor is an investigational, oral, selective inhibitor of Exportin 1 (XPO1), a key nuclear export protein.Currently, its safety, tolerability, and efficacy are being evaluated in adult patients with various relapsed or refractory advanced solid tumors and hematological malignancies.